Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST261 modified-release tablets for mild ulcerative colitis
2011-004770-28Phase 3Completed
- Sponsor
- Leadiant Biosciences
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Propionyl-L-carnitine modified-release tablets with Placebo (2 arms). Primary endpoint: Clinical/endoscopic remission at end of treatment. Started Jan 2012; status: completed.
02
Drugs
propionyl-L-carnitine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2011-004770-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004770-28.